Acute coronary syndrome / myocardial infarction (follow-up)

Fasting laboratory tests

• FBC
• Fasting plasma glucose
• Lipid profile
• Serum creatinine with eGFR
• Serum electrolytesif neededTreatment with ACE inhibitor or ARB: once a year. HAS cites serum potassium and creatinine for dose adjustment, without a specified yearly frequency ^[2]: see the page “Starting or changing the dose of an ACE inhibitor/ARB”.
• ASTif neededTreatment with a statin: 1 to 3 months after the start, then once a year. HAS: transaminases once a year on a statin ^[2]. The “transaminases” code (procedure 0522) is accepted in coronary artery disease for the follow-up of patients on statins ^[3].
• ALTif neededTreatment with a statin: 1 to 3 months after the start, then once a year. HAS: transaminases once a year on a statin ^[2]. The “transaminases” code (procedure 0522) is accepted in coronary artery disease for the follow-up of patients on statins ^[3].
• Creatine kinase (CK)if neededUnexplained muscle symptoms on a statin ^[2]; the NABM accepts CK in coronary artery disease for the follow-up of patients treated with statins ^[3].
• HbA1cif neededKnown diabetes: HbA1c 3 to 4 times a year ^[2]. NABM: HbA1c only in monitoring of glycaemic control ^[3].
• Lipoprotein(a) [Lp(a)], once in a lifetime (not reimbursed in France)if needednon-French guidelineIf never measured: a single measurement is enough in a person suspected of chronic coronary syndrome ^[4]. See the page “Dyslipidaemia”.

Urine tests

• Urine protein:creatinine ratio (spot sample)

Laboratory tests

• Lipid profile
• ALTif needednon-French guidelineStatin started or dose increased: a single ALT check, 8 to 12 weeks after the start or the dose increase, with no routine checks afterwards ^[10]. If the lipid profile is done from 8 weeks, the two are taken together ^[10].